277
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection

, ORCID Icon, ORCID Icon, ORCID Icon &
Pages 2723-2731 | Published online: 05 Aug 2020

References

  • Skraban J, Dzeroski S, Zenko B, Mongus D, Gangl S, Rupnik M. Gut microbiota patterns associated with colonization of different Clostridium difficile ribotypes. PLoS One. 2013;8(2):e58005. doi:10.1371/journal.pone.005800523469128
  • Asempa TE, Nicolau DP. Clostridium difficile infection in the elderly: an update on management. Clin Interv Aging. 2017;12:1799. doi:10.2147/CIA.S14908929123385
  • Barbosa TF, Secco DA, Peixoto RS, et al. Bacterial fecal microbiota in healthy subjects and inpatients with Clostridium difficile infection. Adv Microbiol. 2017;7(01):10. doi:10.4236/aim.2017.71002
  • Tauxe WM, Haydek JP, Rebolledo PA, et al. Fecal microbiota transplant for Clostridium difficile infection in older adults. Therap Adv Gastroenterol. 2016;9(3):273–281. doi:10.1177/1756283X15622600
  • Fischer N, Relman DA. Clostridium Difficile, Aging, and the Gut: Can Microbiome Rejuvenation Keep Us Young and Healthy? Oxford University Press US; 2018.
  • Rea MC, O’Sullivan O, Shanahan F, et al. Clostridium difficile carriage in elderly subjects and associated changes in the intestinal microbiota. J Clin Microbiol. 2012;50(3):867–875. doi:10.1128/JCM.05176-1122162545
  • Rodriguez C, Taminiau B, Korsak N, et al. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol. 2016;16(1):229. doi:10.1186/s12866-016-0848-727716140
  • Milani C, Ticinesi A, Gerritsen J, et al. Gut microbiota composition and Clostridium difficile infection in hospitalized elderly individuals: a metagenomic study. Sci Rep. 2016;6(1):1–12. doi:10.1038/srep2594528442746
  • Shoaei P, Shojaei H, Khorvash F, et al. Molecular epidemiology of Clostridium difficile infection in Iranian hospitals. Antimicrob Resist Infect Control. 2019;8(1):12. doi:10.1186/s13756-018-0454-630675339
  • Samarkos M, Mastrogianni E, Kampouropoulou O. The role of gut microbiota in Clostridium difficile infection. Eur J Intern Med. 2018;50:28–32. doi:10.1016/j.ejim.2018.02.00629428498
  • Lagier J-C. Gut microbiota and Clostridium difficile infections. Human Microbiome J. 2016;2:10–14. doi:10.1016/j.humic.2016.10.003
  • Vakili B, Fateh A, Asadzadeh Aghdaei H, Sotoodehnejadnematalahi F, Siadat SD. Characterization of gut microbiota in hospitalized patients with Clostridioides difficile infection. Curr Microbiol. 2020;15:1–8.
  • Jimeno R, Brailey PM, Barral P. Quantitative polymerase chain reaction-based analyses of murine intestinal microbiota after oral antibiotic treatment. JoVE. 2018;141:e58481.
  • Lemee L, Dhalluin A, Pestel-Caron M, Lemeland J-F, Pons J-L. Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types. J Clin Microbiol. 2004;42(6):2609–2617. doi:10.1128/JCM.42.6.2609-2617.200415184441
  • Shoaei P, Shojaei H, Jalali M, et al. Clostridium difficile isolated from faecal samples in patients with ulcerative colitis. BMC Infect Dis. 2019;19(1):361. doi:10.1186/s12879-019-3965-831039738
  • Pitcher D, Saunders N, Owen R. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett Appl Microbiol. 1989;8(4):151–156. doi:10.1111/j.1472-765X.1989.tb00262.x
  • Shoaei P, Shojaei H, Khorvash F, et al. Clostridium difficile infection in cancer patients with hospital acquired diarrhea at the teaching hospitals in Iran: multilocus sequence typing analysis (MLST) and Antimicrobial resistance pattern. Ann Ig. 2019;31(4):365–373. doi:10.7416/ai.2019.229831268121
  • Stubbs S, Rupnik M, Gibert M, Brazier J, Duerden B, Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett. 2000;186(2):307–312. doi:10.1111/j.1574-6968.2000.tb09122.x10802189
  • Carroll IM, Chang Y-H, Park J, Sartor RB, Ringel Y. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Gut Pathog. 2010;2(1):19. doi:10.1186/1757-4749-2-1921143915
  • Mello CS, Do Carmo Rodrigues MS, de Araújo Filho HB, et al. Fecal microbiota analysis of children with small intestinal bacterial overgrowth among residents of an urban slum in Brazil. Jornal De Pediatria (Versão Em Português). 2018;94(5):483–490. doi:10.1016/j.jpedp.2017.10.012
  • Nabizadeh E, Jazani NH, Bagheri M, Shahabi S. Association of altered gut microbiota composition with chronic urticaria. Ann Allergy Asthma Immunol. 2017;119(1):48–53. doi:10.1016/j.anai.2017.05.00628668239
  • Arvand M, Moser V, Schwehn C, Bettge-Weller G, Hensgens MP, Kuijper J. High prevalence of Clostridium difficile colonization among nursing home residents in Hesse, Germany. PLoS One. 2012;7(1):e30183. doi:10.1371/journal.pone.003018322253917
  • Hegarty JP, Sangster W, Harris III LR, Stewart DB. Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection. Surgery. 2014;156(4):972–978. doi:10.1016/j.surg.2014.06.07425151556
  • Regnault H, Bourrier A, Lalande V, et al. Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment. Dig Liver Dis. 2014;46(12):1086–1092. doi:10.1016/j.dld.2014.09.00325294795
  • Sangster W, Hegarty JP, Schieffer KM, et al. Bacterial and fungal microbiota changes distinguish C. difficile infection from other forms of diarrhea: results of a prospective inpatient study. Front Microbiol. 2016;7:789. doi:10.3389/fmicb.2016.0078927252696
  • Shoaei P, Shojaei H, Shirani K. Phenotypic and genotypic characteristics of Clostridium difficile isolates in patients with type 2 diabetes in Iran. Infect Drug Resist. 2020;13:683. doi:10.2147/IDR.S22582932161476
  • Alimolaei M, Rahimi H-R, Ezatkhah M, Bafti MS, Afzali S. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran. J Glob Antimicrob Resist. 2019;19:22–27. doi:10.1016/j.jgar.2019.02.01330825696
  • Lagier J-C, Million M, Hugon P, Armougom F, Raoult D. Human gut microbiota: repertoire and variations. Front Cell Infect Microbiol. 2012;2:136. doi:10.3389/fcimb.2012.0013623130351
  • Clooney A, Bernstein C, Leslie W, et al. A comparison of the gut microbiome between long‐term users and non‐users of proton pump inhibitors. Aliment Pharmacol Ther. 2016;43(9):974–984. doi:10.1111/apt.1356826923470
  • Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Proton pump inhibitors do not affect risk for Clostridium difficile infection in the intensive care unit. Am J Gastroenterol. 2016;111(11):1641. doi:10.1038/ajg.2016.34327575714
  • Antharam VC, Li EC, Ishmael A, et al. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea. J Clin Microbiol. 2013;51(9):2884–2892. doi:10.1128/JCM.00845-1323804381
  • Kachrimanidou M, Tsintarakis E. Insights into the role of human gut microbiota in Clostridioides difficile infection. Microorganisms. 2020;8(2):200. doi:10.3390/microorganisms8020200
  • Hernández M, de Frutos M, Rodríguez-Lázaro D, López-Urrutia L, Quijada NM, Eiros JM. Fecal microbiota of toxigenic Clostridioides difficile-associated diarrhea. Front Microbiol. 2019;9:3331. doi:10.3389/fmicb.2018.0333130697203
  • Gu S, Chen Y, Zhang X, et al. Identification of key taxa that favor intestinal colonization of Clostridium difficile in an adult Chinese population. Microbes Infect. 2016;18(1):30–38. doi:10.1016/j.micinf.2015.09.00826383014